Welcome to the Fourth 2019 Issue of The CLL Society Tribune
Sincere thanks to all who have given so generously to the CLL Society this year!
For those considering making a contribution, or donating again, please give generously.
Many people you know, and many you do not know, will benefit from your kindness.
We know that…
This year, someone will be startled by a diagnosis.
This year, someone will learn from www.cllsociety.org
what CLL is all about.
This year, someone will feel alone.
This year, someone will be comforted in a
CLL Society Support Group.
This year, someone will try to develop a balanced view of Watch and Wait.
This year, someone will read everything in
Living Well with CLL.
This year, someone will desperately need an expert opinion.
This year, someone will receive a free 2nd Opinion
from a CLL expert in Expert Access.
This year, someone will be taking a medication that we know will not work.
This year, someone will be given a Test Before Treat™ bracelet, read the inside, and change their course of treatment.
This year, someone will need to make a critical treatment decision.
This year, someone will enter a clinical trial that they learned about through the CLL Society.
This year, someone will learn a lot from Patient Educational Forums and CLL Society Webinars.
Take care of someone.
Donateto the CLL Society, where Smart Patients Get Smart Care™.
Patricia Koffman, Executive Director
CLL Society Inc.
CLL Tribune is accepting all forms of storytelling, including articles, poems, drawings, or other creative mediums. Contribute today!
Email email@example.com with your interest!
By Brian Koffman, MD
At the iwCLL (International Workshop on CLL) held this past October in Edinburgh, Scotland, I caught up with Dr. Neil Kay to discuss some of the recent research on predictive and prognostic markers in chronic lymphocytic leukemia presented at the biennial conference. … Watch The Interview
By Richard Furman, MD
Dr. Richard Furman of Weill-Cornell Medical College answers readers’ questions submitted to the CLL Society…Read more
Thomas E Henry III, MBA, RPh, CPh from Burlington Consulting Associates answers readers’ pharmacy questions submitted to the CLL Society…Read more
Susan J. Leclair from University of Massachusetts Dartmouth answers readers’ lab scientist questions submitted to the CLL Society…Read more
We’d like to thank the supporters of The CLL Tribune:
- Genentech/Biogen Idec
- Sunesis Pharmaceuticals
- TG Therapeutics
The CLL Society does not provide medical advice or endorsements. Unless explicitly stated otherwise, all content in the CLL Tribune is the opinion or information of its author, not the CLL Society. This newsletter is for reference and educational purposes only and is not a substitute for medical advice. We do not guarantee the accuracy of any of the materials. Always contact your own doctor or other professional healthcare provider if you have any questions concerning your or your family’s health. Everyone’s circumstances are different.